Jasper Hellweg
Stock Analyst at Argus Research
(4.15)
# 1,598
Out of 5,020 analysts
243
Total ratings
54%
Success rate
7.5%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Upgraded: Buy | $850 | $758.27 | +12.10% | 14 | Oct 1, 2026 | |
| VTRS Viatris | Reiterated: Buy | $20 | $17.72 | +12.87% | 5 | Sep 8, 2026 | |
| ILMN Illumina | Reiterated: Buy | $100 → $235 | $273.68 | -14.13% | 13 | Sep 2, 2026 | |
| MRNA Moderna | Upgraded: Buy | $180 | $192.57 | -6.53% | 15 | Aug 27, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $145 → $170 | $145.31 | +16.99% | 7 | Aug 24, 2026 | |
| AMGN Amgen | Rated: Buy | $360 → $460 | $421.51 | +9.13% | 7 | Aug 18, 2026 | |
| NVO Novo Nordisk | Reiterated: Hold | n/a | $37.91 | - | 8 | Aug 7, 2026 | |
| BMY Bristol-Myers Squibb Company | Upgraded: Buy | $75 | $62.40 | +20.19% | 5 | Aug 4, 2026 | |
| NVS Novartis AG | Reiterated: Buy | $160 → $170 | $142.57 | +19.24% | 3 | Jul 24, 2026 | |
| BIIB Biogen | Reiterated: Hold | n/a | $225.88 | - | 6 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 70.49 | CHF 53.98 | +30.58% | 5 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $22.39 | - | 7 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $48.17 | - | 2 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $69.83 | - | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 → $250 | $261.59 | -4.43% | 5 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $55 | $51.88 | +6.01% | 3 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $345 → $560 | $541.89 | +3.34% | 11 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $149.05 | n/a | 7 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $24.00 | n/a | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $39.60 | n/a | 9 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,157.08 | n/a | 4 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $60 | $41.23 | n/a | 3 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $465 → $550 | $522.81 | n/a | 11 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $125 | $126.35 | n/a | 8 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $70 | $121.35 | n/a | 6 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $26 | $5.14 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $285 → $225 | $137.24 | n/a | 6 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $308.11 | n/a | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 → $165 | $233.07 | n/a | 6 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $475 → $500 | $388.82 | n/a | 5 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 → $290 | $268.85 | n/a | 5 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 → $275 | $426.74 | n/a | 6 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $50 | $43.65 | n/a | 3 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.60 | n/a | 5 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 → $135 | $97.75 | n/a | 5 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 → $115 | $45.18 | n/a | 4 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.76 | n/a | 3 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $312.37 | n/a | 4 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $55.58 | n/a | 1 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $18.89 | n/a | 2 | Aug 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $175.16 | n/a | 1 | Aug 31, 2016 |
Regeneron Pharmaceuticals
Oct 1, 2026
Upgraded: Buy
Price Target: $850
Current: $758.27
Upside: +12.10%
Viatris
Sep 8, 2026
Reiterated: Buy
Price Target: $20
Current: $17.72
Upside: +12.87%
Illumina
Sep 2, 2026
Reiterated: Buy
Price Target: $100 → $235
Current: $273.68
Upside: -14.13%
Moderna
Aug 27, 2026
Upgraded: Buy
Price Target: $180
Current: $192.57
Upside: -6.53%
Merck & Co.
Aug 24, 2026
Reiterated: Buy
Price Target: $145 → $170
Current: $145.31
Upside: +16.99%
Amgen
Aug 18, 2026
Rated: Buy
Price Target: $360 → $460
Current: $421.51
Upside: +9.13%
Novo Nordisk
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $37.91
Upside: -
Bristol-Myers Squibb Company
Aug 4, 2026
Upgraded: Buy
Price Target: $75
Current: $62.40
Upside: +20.19%
Novartis AG
Jul 24, 2026
Reiterated: Buy
Price Target: $160 → $170
Current: $142.57
Upside: +19.24%
Biogen
Jul 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $225.88
Upside: -
Jul 1, 2026
Reiterated: Buy
Price Target: CHF 70.49
Current: CHF 53.98
Upside: +30.58%
Jun 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.39
Upside: -
Jun 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $48.17
Upside: -
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $69.83
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: $220 → $250
Current: $261.59
Upside: -4.43%
Apr 6, 2026
Upgraded: Buy
Price Target: $55
Current: $51.88
Upside: +6.01%
Mar 3, 2026
Rated: Buy
Price Target: $345 → $560
Current: $541.89
Upside: +3.34%
May 5, 2025
Reiterated: Buy
Price Target: $100 → $120
Current: $149.05
Upside: n/a
Feb 24, 2025
Upgraded: Buy
Price Target: $40
Current: $24.00
Upside: n/a
Jan 30, 2025
Reiterated: Buy
Price Target: $20
Current: $39.60
Upside: n/a
Jan 22, 2025
Reiterated: Buy
Price Target: n/a
Current: $1,157.08
Upside: n/a
Jul 26, 2024
Reiterated: Buy
Price Target: $55 → $60
Current: $41.23
Upside: n/a
Jun 17, 2024
Reiterated: Buy
Price Target: $465 → $550
Current: $522.81
Upside: n/a
Apr 29, 2024
Reiterated: Buy
Price Target: $105 → $125
Current: $126.35
Upside: n/a
Apr 25, 2024
Reiterated: Buy
Price Target: $90 → $70
Current: $121.35
Upside: n/a
Dec 7, 2022
Upgraded: Buy
Price Target: $26
Current: $5.14
Upside: n/a
Oct 24, 2022
Reiterated: Buy
Price Target: $285 → $225
Current: $137.24
Upside: n/a
Sep 19, 2022
Downgraded: Hold
Price Target: n/a
Current: $308.11
Upside: n/a
Aug 17, 2022
Reiterated: Buy
Price Target: $135 → $165
Current: $233.07
Upside: n/a
Feb 7, 2022
Reiterated: Buy
Price Target: $475 → $500
Current: $388.82
Upside: n/a
Sep 10, 2021
Reiterated: Buy
Price Target: $260 → $290
Current: $268.85
Upside: n/a
Aug 2, 2021
Reiterated: Buy
Price Target: $195 → $275
Current: $426.74
Upside: n/a
Jun 7, 2021
Reiterated: Buy
Price Target: $43 → $50
Current: $43.65
Upside: n/a
May 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $6.60
Upside: n/a
May 3, 2021
Reiterated: Buy
Price Target: $95 → $135
Current: $97.75
Upside: n/a
Jun 12, 2020
Reiterated: Buy
Price Target: $135 → $115
Current: $45.18
Upside: n/a
Apr 17, 2020
Downgraded: Hold
Price Target: n/a
Current: $14.76
Upside: n/a
Mar 24, 2020
Downgraded: Hold
Price Target: n/a
Current: $312.37
Upside: n/a
Oct 30, 2019
Downgraded: Hold
Price Target: n/a
Current: $55.58
Upside: n/a
Aug 15, 2019
Upgraded: Buy
Price Target: $40
Current: $18.89
Upside: n/a
Aug 31, 2016
Downgraded: Hold
Price Target: n/a
Current: $175.16
Upside: n/a